雷帕鸣的最新价格
Also known as sirolimus, as early as 1989, Morris officially began to study this drug as a new and highly effective immunosuppressant for the anti-rejection effect of organ transplantation. The results showed that its effective anti-proliferative effect on peripheral blood mononuclear cells is 50 to 500 times stronger than that of cyclosporine CA, but its nephrotoxicity is lower than that of cyclosporine and tacrolix.
In 1999, Rapamin was officially approved by the US FDA for the treatment of kidney transplant patients aged 13 or above to prevent organ rejection. Recommended for use in combination with cyclosporine and corticosteroids. In 2002, Rapamin was approved for marketing in my country, bringing new options for the treatment of domestic patients.
The domestic manufacturer of the original drug Rapamin is Pfizer Pharmaceuticals. Although it has been on the market in China for many years, the price of the original drug is usually relatively high. Therefore, more and more patients tend to buy Rapamin produced by Biocon in India.
Biocon is one of India's three largest biotechnology companies, and its goal is to achieve health equity. The four global businesses include generic drugs, biosimilars, research services and novel biologics. Achieve scale, speed and quality by leveraging the value advantages of India's unparalleled scientific talent and cost-competitive manufacturing. We are working towards health equity by making medicines more accessible to patients around the world.
Since the investment cost of Rapamide produced by India's Biocon Company is relatively low, the price is also relatively low. The specifications are 1mgx10 tablets and the price is around 200$. Patients can go to a regular Indian pharmacy to buy it with a doctor's prescription. If it is inconvenient to go abroad, you can consult the Medical Travel Overseas Medical Consulting Service Company for detailed information.
The above is the price introduction of Biocon in India. If you have other questions about drug purchase, you can further consult the medical companion travel service for answers.
Recommended related hot articles: /newsDetail/86899.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)